SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngioma. (2019)
Attributed to:
Molecular and Cellular Mechanisms Underlying Pituitary Tumours
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1530/erc-18-0538
PubMed Identifier: 30645190
Publication URI: http://europepmc.org/abstract/MED/30645190
Type: Journal Article/Review
Volume: 26
Parent Publication: Endocrine-related cancer
Issue: 3
ISSN: 1351-0088